Assignee
BIOXCEL CORP
US·2 granted patents·7 pending applications·0 citations·filing 2014–2017
Top patents by PatentIndex Score
9 records- 0141US2016063202A1Systems and methods to classify and rank health informationBIOXCEL CORP·Filed 2014·Application pending·0 cites
- 0239US10610563B2Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2BIOXCEL CORP·Filed 2015·Granted Apr 7, 2020·0 cites·25 claims
- 0339US2017239221A1Prevention or treatment of sleep disorders using dexmedetomidine formulationBIOXCEL CORP·Filed 2015·Application pending·0 cites
- 0435US2019298720A1Use of src family kinase inhibitor in ribosomal disorderBIOXCEL CORP·Filed 2017·Application pending·0 cites
- 0530US2018226156A1Methods for assessing pharmaceutical performance across therapeutic areas and devices thereofBIOXCEL CORP·Filed 2015·Application pending·0 cites
- 0629US2019008918A1Immunomodulation therapies for cancerBIOXCEL CORP·Filed 2017·Application pending·0 cites
- 0725US10572631B2Methods for reformulating and repositioning pharmaceutical data and devices thereofBIOXCEL CORP·Filed 2015·Granted Feb 25, 2020·0 cites·18 claims
- 0824US2018094058A1Compositions and methods for preventing tumor growth and treating cancer by targeting lectin galactoside-binding soluble 3 binding proteinBIOXCEL CORP·Filed 2016·Application pending·0 cites
- 0919US2018134771A1Novel immunomodulatory therapeutic strategies targeting tumors in cancerBIOXCEL CORP·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →